Search Thermo Fisher Scientific
Transfection Reagents |
Since launching in 1993, Invitrogen Lipofectamine reagents have become the most referenced transfection reagents with over 50,000 citations. You continue to choose these reagents due to their wide acceptance as the best and most reliable available. Lipofectamine reagents offer you the ability to consistently transfect many cell types with high efficiency and exceptional ease of use.
Our Lipofectamine reagent-specific protocols have been optimized for efficiency, viability, and reproducibility across a broad range of cell types (see "Download protocol" links in the table below). This can be a great place to start especially in a new cell line. If you find this doesn’t work for your specific cell type, then you can you look to our cell-specific protocols for further optimization.
Find products, citations, and protocols optimized for your transfection experiments. Input information on your experiment type, cell line, and payload to unlock solutions.
We offer transfection reagents for DNA, siRNA, RNA, and protein delivery, providing a range of options to suit your transfection experiment:
When selecting a transfection method, consider the payload you wish to deliver (DNA, RNA, or protein) and the type of cells you want to transfect. Use the selection guide below to choose between our various cationic-lipid transfection reagents and our electroporation transfection system.
Continuous cell lines are capable of unlimited proliferative potential, and are generally easier to work with than primary or finite cell cultures. However, because these cells have undergone genetic transformation to become immortalized, their behavior in culture may not necessarily reflect the in vivo situation.
Reagent | DNA | mRNA | RNAi | Co- delivery | CRISPR-Cas9 | Antibody | Cell type(s) | Adherent or suspension |
---|---|---|---|---|---|---|---|---|
Lipofectamine 2000 | Common and easy-to-transfect cell types | Adherent and suspension | ||||||
Lipofectamine 3000 | Workhorse (HeLa) through to hard-to-transfect (cancer cells) | Adherent | ||||||
Lipofectamine LTX | CHO cells and some primary fibroblast, epithelial, and neuronal cells (MEF, HMEC, and E18 cells) | Adherent | ||||||
Lipofectamine RNAiMAX | Established cell lines, hard-to-transfect cells, primary cells, stem cells | Adherent | ||||||
Lipofectamine MessengerMAX | Neuronal cells, primary cells | Adherent | ||||||
Lipofectamine CRISPRMAX | Tested in over 20 cell types including iPSC, mESC, N2A, CHO, A549, HCT116, HeLa, HEK293, and several others | Adherent | ||||||
Neon NxT Electroporation System | Suspension | |||||||
Invivofectamine 3.0 | In vivo delivery to liver following tail vein injection |
Primary cells are isolated directly from the tissue and proliferated under appropriate conditions. As such, they are morphologically and physiologically more similar to an in vivo state. However, they are usually more difficult to culture and transfect than continuous cell lines.
After the first subculture, the primary culture becomes known as a cell line. Cell lines derived from primary cultures have a limited life span (i.e., they are finite), and as they are passaged, cells with the highest growth capacity predominate, resulting in a degree of genotypic and phenotypic uniformity in the population. Therefore, their phenotype is intermediate between primary cells and continuous cultures. The use of such cells is sometimes easier than the use of primary cells, especially for the generation of stably transfected clones.
Reagent | DNA | mRNA | RNAi | Co-delivery | CRISPR-Cas9 | Antibody | Cell type(s) | Adherent or suspension |
---|---|---|---|---|---|---|---|---|
Lipofectamine 2000 | Neuronal cells | Adherent and suspension | ||||||
Lipofectamine 3000 | Workhorse (HeLa) through to hard-to-transfect (cancer cells) | Adherent | ||||||
Lipofectamine Stem | Stem cells (except HSCs) | Adherent and suspension | ||||||
Lipofectamine LTX | CHO cells and some primary fibroblast, epithelial, and neuronal cells (MEF, HMEC, and E18 cells) | Adherent | ||||||
Lipofectamine CRISPRMAX | Tested in over 20 cells types including iPSC, mESC, N2A, CHO, A549, HCT116, HeLa, HEK293, and several others | Adherent | ||||||
Lipofectamine RNAiMAX | Established cell lines, hard-to-transfect cells, primary cells, stem cells | Adherent | ||||||
Lipofectamine MessengerMAX | Neuronal cells, primary cells | Adherent | ||||||
Neon NxT Electroporation System | Over 140 cell lines tested; excels in hard-to-transfect cells, primary cells, and stem cells | Suspension |
Continuous cell lines are capable of unlimited proliferative potential, and are generally easier to work with than primary or finite cell cultures. However, because these cells have undergone genetic transformation to become immortalized, their behavior in culture may not necessarily reflect the in vivo situation.
Reagent | DNA | mRNA | RNAi | Co- delivery | CRISPR-Cas9 | Antibody | Cell type(s) | Adherent or suspension |
---|---|---|---|---|---|---|---|---|
Lipofectamine 2000 | Common and easy-to-transfect cell types | Adherent and suspension | ||||||
Lipofectamine 3000 | Workhorse (HeLa) through to hard-to-transfect (cancer cells) | Adherent | ||||||
Lipofectamine LTX | CHO cells and some primary fibroblast, epithelial, and neuronal cells (MEF, HMEC, and E18 cells) | Adherent | ||||||
Lipofectamine RNAiMAX | Established cell lines, hard-to-transfect cells, primary cells, stem cells | Adherent | ||||||
Lipofectamine MessengerMAX | Neuronal cells, primary cells | Adherent | ||||||
Lipofectamine CRISPRMAX | Tested in over 20 cell types including iPSC, mESC, N2A, CHO, A549, HCT116, HeLa, HEK293, and several others | Adherent | ||||||
Neon NxT Electroporation System | Suspension | |||||||
Invivofectamine 3.0 | In vivo delivery to liver following tail vein injection |
Primary cells are isolated directly from the tissue and proliferated under appropriate conditions. As such, they are morphologically and physiologically more similar to an in vivo state. However, they are usually more difficult to culture and transfect than continuous cell lines.
After the first subculture, the primary culture becomes known as a cell line. Cell lines derived from primary cultures have a limited life span (i.e., they are finite), and as they are passaged, cells with the highest growth capacity predominate, resulting in a degree of genotypic and phenotypic uniformity in the population. Therefore, their phenotype is intermediate between primary cells and continuous cultures. The use of such cells is sometimes easier than the use of primary cells, especially for the generation of stably transfected clones.
Reagent | DNA | mRNA | RNAi | Co-delivery | CRISPR-Cas9 | Antibody | Cell type(s) | Adherent or suspension |
---|---|---|---|---|---|---|---|---|
Lipofectamine 2000 | Neuronal cells | Adherent and suspension | ||||||
Lipofectamine 3000 | Workhorse (HeLa) through to hard-to-transfect (cancer cells) | Adherent | ||||||
Lipofectamine Stem | Stem cells (except HSCs) | Adherent and suspension | ||||||
Lipofectamine LTX | CHO cells and some primary fibroblast, epithelial, and neuronal cells (MEF, HMEC, and E18 cells) | Adherent | ||||||
Lipofectamine CRISPRMAX | Tested in over 20 cells types including iPSC, mESC, N2A, CHO, A549, HCT116, HeLa, HEK293, and several others | Adherent | ||||||
Lipofectamine RNAiMAX | Established cell lines, hard-to-transfect cells, primary cells, stem cells | Adherent | ||||||
Lipofectamine MessengerMAX | Neuronal cells, primary cells | Adherent | ||||||
Neon NxT Electroporation System | Over 140 cell lines tested; excels in hard-to-transfect cells, primary cells, and stem cells | Suspension |
Symbol | Explanation | Symbol | Explanation |
---|---|---|---|
DNA for expression of protein, shRNA, and miRNA | mRNA for expression of protein | ||
Non-coding RNA for RNAi inhibition of gene expression | Co-delivery for cotransfection of RNAi vectors and siRNAs | ||
CRISPR-Cas9 for protein delivery | Antibody for protein tracing, therapeutics, disease pathogenesis |
Cationic lipid based-based transfection is the most popular chemical transfection method. Known for their ease of use, the Lipofectamine reagents are categorized below based on their payloads.
Invitrogen Lipofectamine 2000 Transfection Reagent is well-suited for common and easy-to-transfect cell types. It is widely used in transfection experiments that require dependability, allowing researchers to focus on more important variables. This broad-spectrum versatility is derived from a simple protocol and well-known ability to work across several applications. Transfection conditions can be easily established for high-throughput applications involving automated or robotic systems. Lipofectamine 2000 is the best choice for establishing stable cell lines and the transfection of neuronal cells. It is effective in co-delivering both plasmid DNA and siRNA. This reagent is recommended for use with neurons over Lipofectamine 3000.
Invitrogen Lipofectamine 3000 Transfection Reagent is our highest efficiency reagent for difficult-to-transfect cells. This product offers versatility for DNA, RNA, and co-transfection use. The customizable, and highly efficient two-tube formulation provides you with ultimate flexibility to tailor your transfection to the needs of specific cell types, including primary cells, stem cells, and cancer cell lines.
Invitrogen Lipofectamine LTX Reagent with PLUS reagent combines high efficiency and cell viability with a quick, simple protocol for gentle DNA plasmid delivery. With an easy two-tube optimization, Lipofectamine LTX reagent delivers the right balance between potency and gentleness. The reagent offers exceptional transfection efficiency in CHO, primary fibroblast, and epithelial cells (MEF and HMEC cells).
Invitrogen Lipofectamine MessengerMAX Transfection Reagent is designed to transfect neurons and a broad spectrum of difficult-to-transfect primary cells with a larger amount of mRNA. This results in a more than two-fold improvement in transfection efficiency compared to other lipid-based reagents. Transfection of mRNA with Lipofectamine MessengerMAX reagent results in faster protein expression because translation of mRNA occurs in the cytoplasm. Additionally, delivery of mRNA does not require nuclear entry, which eliminates the risk of genomic integration and enables high transfection efficiency in slowly dividing cells. Expect up to 10x higher cleavage using mRNA CRISPRs.
Invitrogen Lipofectamine RNAiMAX Transfection Reagent offers the highest transfection efficiencies on the widest variety of cell types for siRNA-mediated gene knockdown experiments, including high-throughput applications. A proprietary RNAi-specific cationic lipid formulation is designed for robust delivery of siRNA and miRNA into all cell types, especially when combined with Invitrogen Silencer Select siRNA. The simple, rapid protocol accommodates lower siRNA concentrations, thus enabling more effective gene knockdown with minimal nonspecific effects. Lipofectamine RNAiMAX is ideal for high-throughput siRNA transfections. Expect easy optimization due to minimal cytotoxicity across a 10-fold concentration range.
Invitrogen Invivofectamine 3.0 Reagent is a breakthrough, animal origin-free reagent for in vivo siRNA delivery. Improved performance and up to 85% knockdown can be achieved using microgram levels of siRNA. Creating complexes of Invivofectamine 3.0 Reagent and siRNA duplexes for delivery is easy; simply mix, incubate, and dilute. Expect low toxicity and highly effective knockdown.
Invitrogen Lipofectamine CRISPRMAX Cas9 Transfection Reagent is the first optimized lipid nanoparticle transfection reagent for delivery of ribonucleoprotein (RNP) complexes for CRISPR-Cas9 genome editing. It is a high throughput–compatible, cost-effective alternative to electroporation. Working together with Invitrogen TrueCut Cas9 Protein v2 and Invitrogen TrueGuide Synthetic gRNA, it provides demonstrated cleavage efficiency, low cell toxicity, and cost savings. Unlike CRISPR plasmids or Cas9 mRNA, using Cas9 protein provides superior cleavage efficiency in primary cells and stem cells. It eliminates the need for transcription or translation of the payload, removes the risk of genomic integration, and is cell cycle independent.
Shop Lipofectamine CRISPRMAX
Learn more about CRISPR transfection
Invitrogen Lipofectamine Stem Transfection Reagent is designed to efficiently deliver DNA, RNA, or Cas9 protein complexes into stem cells which are typically hard to transfect via reagent-based transfection methods. Lipofectamine Stem reagent is up to 3x more efficient than existing transfection reagents in iPSCs, NSCs, and MSCs. The reagent is suitable for transfection into adherent or suspension cells and is gently enough to support cell proliferation without inducing differentiation.
Find essential products to help you at every step of the way from cell preparation for transfection to selection and analysis of transfected cells.
Xavier de Mollerat du Jeu, Sr. Staff Scientist, discusses the transfection research program and key factors for successful transfections, which resulted in enhanced protocols for the Lipofectamine line of transfection reagents.
In addition to our large selection of transfection reagents, explore Gibco selection antibiotics, which provide unique solutions for your transfection experiments, including dual selection and rapid cell line establishment.
Packaging must protect the product inside—but that doesn’t have to mean sacrificing sustainability. Lipofectamine products are shipped at ambient temperature, diverting 24,000 ft3 of Expanded Polystyrene (EPS) coolers from landfills annually. We reduce the carbon footprint from packaging and shipping these products by 80 tons (CO2 equivalents).
Learn more about sustainable solutions
Download the green fact sheet
Our Lipofectamine reagent-specific protocols have been optimized for efficiency, viability, and reproducibility across a broad range of cell types. Search this library to find protocols and citations curated to fit your experimental needs. Filter by cell type, payload, and product of choice to easily unlock your answers.
In addition, please view other useful resources:
Search our extensive collection of Transfection FAQs to find the answers you need. Input key terms for your transfection questions to discover a collection of carefully curated and regularly updated answers.
For Research Use Only. Not for use in diagnostic procedures.